The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis. (Q51130038)
Jump to navigation
Jump to search
scientific article published on 19 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis. |
scientific article published on 19 March 2009 |
Statements
The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis. (English)
1 reference
P S Sorensen
1 reference
N Koch-Henriksen
1 reference
K Bendtzen
1 reference
E M Flachs
1 reference
19 March 2009
1 reference
15
1 reference
5
1 reference
601-605
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference